Ontology highlight
ABSTRACT: Background
Novel therapies are crucial for patients with major depressive disorder, as more than 33% of patients do not respond to first-line treatments. A promising novel treatment strategy is an intensive 5-day course of personalized, functional connectivity-guided accelerated intermittent theta-burst stimulation (PAiT), modeled after the Stanford neuromodulation therapy protocol. This new form of repetitive transcranial magnetic stimulation (rTMS) may lead to higher remission rates in patients with treatment-resistant depression (TRD). However, it remains unclear how this accelerated strategy compares to the standard once-daily 10 Hz rTMS at inducing remission of depression.Objective
This study aims to compare cost-effectiveness using the PAiT protocol and the standard 1
SUBMITTER: Dols A
PROVIDER: S-EPMC12411794 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature